Comac Medical is pleased to announce our participation in the 23rd BioPharma Drug Discovery Nexus Conference, taking place on May 7–8, 2025, at the Embassy Suites by Hilton in San Francisco, California. This premier event brings together over 150 scientific leaders, 20+ cutting-edge exhibitors, and facilitates more than 300 one-to-one meetings, fostering collaboration and innovation in the field of drug discovery.

Representing Comac Medical at this year’s conference is Kelly Conti, our newly appointed Senior Business Development Director. With a wealth of experience in clinical research and a passion for fostering strategic partnerships, Kelly is eager to engage with fellow professionals to explore opportunities that drive advancements in drug development.​

The conference agenda is meticulously curated to delve into the latest trends and innovations in drug discovery, including novel target identification, AI-driven drug design, and the revolutionary potential of cell and gene therapies. Attendees will gain invaluable insights from a diverse range of tracks and sessions designed to shape the future of medicine.

Comac Medical is committed to expanding our capabilities in early-phase clinical research and embracing innovative approaches to drug development. Our participation in the BioPharma Drug Discovery Nexus Conference underscores our dedication to collaborating with industry leaders to bring life-changing therapies to patients worldwide.​

We invite you to meet with Kelly Conti during the conference to discuss potential collaborations and learn more about Comac Medical’s comprehensive clinical research solutions.